Dysadherin expression in head and neck squamous cell carcinoma: Association with lymphangiogenesis and prognostic significance

American Journal of Surgical Pathology

Volumn 30, Issue 2, 2006, Pages 185-193

  Kyzas, Panayiotis A ^a   Stefanou, Dimitrios ^a   Batistatou, Anna ^a   Agnantis, Niki J ^a   Nakanishi, Yukihiro ^b   Hirohashi, Setsuo ^b   Charalabopoulos, Konstantinos ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

D2 40; Dysadherin; E cadherin; Lymphangiogenesis; Metastasis

Indexed keywords

BIOLOGICAL MARKER; CELL MEMBRANE PROTEIN; DYSADHERIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; FXYD5 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D2 40; MONOCLONAL ANTIBODY D2-40; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; CANCER PATIENT; CANCER STAGING; CELL ADHESION; DISEASE ASSOCIATION; HEAD AND NECK CARCINOMA; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE SECTION; ADULT; AGED; BIOSYNTHESIS; HEAD AND NECK TUMOR; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL ENDOTHELIUM; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; ENDOTHELIUM, LYMPHATIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33645218212     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000178090.54147.f8     Document Type: Article

References (33)

1. Altman DG, Lausen B, Sauerbrei W, et al. Dangers of using 'optimal' cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 1994;86:829-835.
2. Aoki S, Shimamura T, Shibata T, et al. Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br J Cancer. 2003;88:726-732.
3. Beasley NJ, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res. 2002;62:1315-1320.
4. Bosch FX, Andl C, Abel U, et al. E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components. Int J Cancer. 2005;114:779-790.
5. Bryant DM, Stow JL. The ins and outs of E-cadherin trafficking. Trends Cell Biol. 2004;14:427-434.
6. Bryne M, Boysen M, Alfsen CG, et al. The invasive front of carcinomas: the most important area for tumour prognosis? Anticancer Res. 1998;6B:4757-4764.
7. Chang HW, Chow V, Lam KY, et al. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer. 2002;94:386-392.
8. Charalabopoulos K, Gogali A, Kostoula OK, et al. Cadherin superfamily of adhesion molecules in primary lung cancer. Exp Oncol. 2004;26:256-260.
9. Evangelou E, Kyzas PA, Trikalinos TA. Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach. Mod Pathol. 2005. [Epub 2005 July 1] doi:10.1038/modpathol.3800457.
10. Franchi A, Gallo O, Boddi V, et al. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin Cancer Res. 1996;2:1801-1808.
11. Franchi A, Gallo O, Massi D, et al. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer. 2004;101:973-978.
12. Gupta A, Deshpande CG, Badve S. Role of E-cadherins in development of lymphatic tumor emboli. Cancer. 2003;97:2341-2347.
13. Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci. 2003;94:575-581.
14. Ino Y, Gotoh M, Sakamoto M, et al. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci USA. 2002;99:365-370. [Epub 2001 Dec 26]
15. Kawano T, Nakamura Y, Yanoma S, et al. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer. Auris Nasus Larynx. 2004;31:35-41.
16. Kyzas PA, Geleff S, Batistatou A, et al. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol. 2005;206:170-177.
17. Lim SC, Zhang S, Ishii G, et al. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res. 2004;10:166-172.
18. Marcus B, Arenberg D, Lee J, et al. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer. 2004;101:2779-2787.
19. Maula SM, Luukkaa M, Grenman R, et al. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res. 2003;63:1920-1926.
20. Nakamura E, Sugihara H, Bamba M, et al. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas. J Pathol. 2005;205:349-358.
21. Nakanishi Y, Akimoto S, Sato Y, et al. Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases. Appl Inmninohistochem Mol Morphol. 2004;12:323-328.
22. Sato H, Ino Y, Miura A, et al. Dysadherin: expression and clinical significance in thyroid carcinoma. J Clin Endocrinol Metab. 2003;88:4407-4412.
23. Schoppmann SF, Bayer G, Aumayr K, et al. Austrian Breast and Colorectal Cancer Study Group: prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg. 2004;240:306-312.
24. Shimamura T, Sakamoto M, Ino Y, et al. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression. J Clin Oncol. 2003;21:659-667.
25. Shimamura T, Yasuda J, Ino Y, et al. Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells. Cancer Res. 2004;64:6989-6995.
26. Shimada Y, Yamasaki S, Hashimoto Y, et al. Clinical significance of dysadherin expression in gastric cancer patients. Clin Cancer Res. 2004; 10:2818-2823. Erratum in Clin Cancer Res. 2004;10:4198.
27. Shimada Y, Hashimoto Y, Kan T, et al. Prognostic significance of dysadherin expression in esophageal squamous cell carcinoma. Oncology. 2004;67:73-80.
28. Stacker SA, Achen MG, Jussila L, et al. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002;2:573-583.
29. Takes RP, Baatenburg De Jong RJ, Takes RP, et al. Markers for nodal metastasis in head and neck squamous cell cancer. Arch Otolaryngol Head Neck Surg. 2002;128:512-518.
30. Tanaka N, Odajima T, Ogi K, et al. Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer. 2003;89:557-563.
31. Tsuiji H, Takasaki S, Sakamoto M, et al. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion. Glycobiology. 2003;13:521-527. [Epub 2003 Apr 02]
32. Wu D, Qiao Y, Kristensen GB, et al. Prognostic significance of dysadherin expression in cervical squamous cell carcinoma. Pathol Oncol Res. 2004;10:212-218. [Epub 2004 Dec 27]
33. Yanagihara K, Tanaka H, Takigahira M, et al. Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Sci. 2004;95:575-582.